HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meth bill vote pledged

This article was originally published in The Tan Sheet

Executive Summary

Senate leadership has agreed to vote in January or early February on legislation that would put OTC cough/cold products containing pseudoephedrine behind the counter, according to Combat Meth Act cosponsor Sen. Dianne Feinstein (D-Calif.). A version of the bill was attached to the Patriot Act reauthorization conference report but was left behind when the Senate reached a compromise Dec. 22 to extend Patriot by five weeks without the report. Feinstein is considering seeking another vehicle or attempting to pass the meth Act as a stand-alone bill; however, according to her office, the bill likely will resurface as an amendment to the Patriot Act, which will require reauthorization prior to Feb. 3...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098959

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel